JP2008515770A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008515770A5 JP2008515770A5 JP2007519691A JP2007519691A JP2008515770A5 JP 2008515770 A5 JP2008515770 A5 JP 2008515770A5 JP 2007519691 A JP2007519691 A JP 2007519691A JP 2007519691 A JP2007519691 A JP 2007519691A JP 2008515770 A5 JP2008515770 A5 JP 2008515770A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- peptide
- prevention
- optionally
- residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002265 prevention Effects 0.000 claims description 21
- 150000001875 compounds Chemical class 0.000 claims description 11
- 239000002537 cosmetic Substances 0.000 claims description 9
- 210000003491 skin Anatomy 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 5
- 230000009759 skin aging Effects 0.000 claims description 5
- 210000002615 epidermis Anatomy 0.000 claims description 4
- 230000008719 thickening Effects 0.000 claims description 4
- 230000037303 wrinkles Effects 0.000 claims description 4
- 208000024891 symptom Diseases 0.000 claims description 3
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 2
- 208000035484 Cellulite Diseases 0.000 claims description 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims description 2
- 102000005741 Metalloproteases Human genes 0.000 claims description 2
- 108010006035 Metalloproteases Proteins 0.000 claims description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 2
- 206010049752 Peau d'orange Diseases 0.000 claims description 2
- 102000035195 Peptidases Human genes 0.000 claims description 2
- 108091005804 Peptidases Proteins 0.000 claims description 2
- 239000004365 Protease Substances 0.000 claims description 2
- 208000003251 Pruritus Diseases 0.000 claims description 2
- 201000004681 Psoriasis Diseases 0.000 claims description 2
- 230000003255 anti-acne Effects 0.000 claims description 2
- 201000008937 atopic dermatitis Diseases 0.000 claims description 2
- 208000010668 atopic eczema Diseases 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 230000036232 cellulite Effects 0.000 claims description 2
- 229940106189 ceramide Drugs 0.000 claims description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 2
- 230000018109 developmental process Effects 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 208000035475 disorder Diseases 0.000 claims description 2
- 230000037336 dry skin Effects 0.000 claims description 2
- 230000036074 healthy skin Effects 0.000 claims description 2
- 230000013632 homeostatic process Effects 0.000 claims description 2
- 230000002757 inflammatory effect Effects 0.000 claims description 2
- 230000005764 inhibitory process Effects 0.000 claims description 2
- 230000007803 itching Effects 0.000 claims description 2
- 150000002632 lipids Chemical class 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000011159 matrix material Substances 0.000 claims description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 2
- 230000036542 oxidative stress Effects 0.000 claims description 2
- 230000008832 photodamage Effects 0.000 claims description 2
- 210000002374 sebum Anatomy 0.000 claims description 2
- 230000037307 sensitive skin Effects 0.000 claims description 2
- 210000004927 skin cell Anatomy 0.000 claims description 2
- 238000003786 synthesis reaction Methods 0.000 claims description 2
- 229940024606 amino acid Drugs 0.000 claims 19
- 235000001014 amino acid Nutrition 0.000 claims 19
- 150000001413 amino acids Chemical group 0.000 claims 18
- 108090000765 processed proteins & peptides Chemical group 0.000 claims 15
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims 9
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims 9
- 229960002591 hydroxyproline Drugs 0.000 claims 9
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 6
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 claims 6
- 210000004899 c-terminal region Anatomy 0.000 claims 6
- 150000002148 esters Chemical class 0.000 claims 6
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 6
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 6
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 claims 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 3
- 239000004475 Arginine Substances 0.000 claims 3
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 3
- 239000004215 Carbon black (E152) Substances 0.000 claims 3
- 108010016626 Dipeptides Proteins 0.000 claims 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 3
- 239000004471 Glycine Substances 0.000 claims 3
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 claims 3
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 claims 3
- SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 claims 3
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 3
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 3
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 claims 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 3
- SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 claims 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 3
- 239000004472 Lysine Substances 0.000 claims 3
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 claims 3
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims 3
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 3
- 108010077895 Sarcosine Proteins 0.000 claims 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 3
- 239000004473 Threonine Substances 0.000 claims 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 3
- 229960003121 arginine Drugs 0.000 claims 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 3
- 229960001230 asparagine Drugs 0.000 claims 3
- 235000009582 asparagine Nutrition 0.000 claims 3
- 229960005261 aspartic acid Drugs 0.000 claims 3
- 235000003704 aspartic acid Nutrition 0.000 claims 3
- 229940000635 beta-alanine Drugs 0.000 claims 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 3
- 229960002173 citrulline Drugs 0.000 claims 3
- 235000013477 citrulline Nutrition 0.000 claims 3
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 claims 3
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical group NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 claims 3
- 229960002989 glutamic acid Drugs 0.000 claims 3
- 235000013922 glutamic acid Nutrition 0.000 claims 3
- 239000004220 glutamic acid Substances 0.000 claims 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 3
- 229960002743 glutamine Drugs 0.000 claims 3
- 235000004554 glutamine Nutrition 0.000 claims 3
- 229960002885 histidine Drugs 0.000 claims 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 3
- 229930195733 hydrocarbon Natural products 0.000 claims 3
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 claims 3
- 229960000310 isoleucine Drugs 0.000 claims 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 3
- 229960003136 leucine Drugs 0.000 claims 3
- 229960003646 lysine Drugs 0.000 claims 3
- 235000018977 lysine Nutrition 0.000 claims 3
- 229960003104 ornithine Drugs 0.000 claims 3
- 229960005190 phenylalanine Drugs 0.000 claims 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 3
- 229960002429 proline Drugs 0.000 claims 3
- 229940043230 sarcosine Drugs 0.000 claims 3
- 229960001153 serine Drugs 0.000 claims 3
- 229960003080 taurine Drugs 0.000 claims 3
- 229960002898 threonine Drugs 0.000 claims 3
- 229960004799 tryptophan Drugs 0.000 claims 3
- 229960004295 valine Drugs 0.000 claims 3
- 239000004474 valine Substances 0.000 claims 3
- FPDYKABXINADKS-LURJTMIESA-N (2s)-2-(methylazaniumyl)hexanoate Chemical compound CCCC[C@H](NC)C(O)=O FPDYKABXINADKS-LURJTMIESA-N 0.000 claims 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 2
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 claims 2
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 229960002433 cysteine Drugs 0.000 claims 2
- 235000018417 cysteine Nutrition 0.000 claims 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 2
- 229930182817 methionine Natural products 0.000 claims 2
- 229960004452 methionine Drugs 0.000 claims 2
- 229960002718 selenomethionine Drugs 0.000 claims 2
- 206010058314 Dysplasia Diseases 0.000 claims 1
- 208000019028 Epidermal thickening Diseases 0.000 claims 1
- 206010041303 Solar dermatitis Diseases 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 206010047642 Vitiligo Diseases 0.000 claims 1
- 230000032683 aging Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 claims 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 206010036087 Polymorphic light eruption Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04016239 | 2004-07-09 | ||
| PCT/EP2005/007134 WO2006005455A2 (en) | 2004-07-09 | 2005-07-01 | Amino, amino acid or peptide conjugates of retinoic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008515770A JP2008515770A (ja) | 2008-05-15 |
| JP2008515770A5 true JP2008515770A5 (https=) | 2011-09-29 |
Family
ID=35062952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007519691A Pending JP2008515770A (ja) | 2004-07-09 | 2005-07-01 | レチノイン酸のアミノ、アミノ酸またはペプチド結合体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20070270472A1 (https=) |
| EP (1) | EP1765773A2 (https=) |
| JP (1) | JP2008515770A (https=) |
| KR (1) | KR20070038509A (https=) |
| CN (1) | CN101048375B (https=) |
| BR (1) | BRPI0513145A (https=) |
| WO (1) | WO2006005455A2 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5572318B2 (ja) * | 2005-12-30 | 2014-08-13 | ルバンス セラピュティックス インク． | 局所投与用アルギニンヘテロマー |
| US20100222275A1 (en) * | 2007-10-19 | 2010-09-02 | Kunihiko Tamaki | Therapeutic agent for vitiligo and method of accelerating pigmentation |
| KR101740353B1 (ko) * | 2009-09-29 | 2017-05-26 | 가부시키가이샤 시세이도 | 항산화 조성물 |
| JP5864615B2 (ja) * | 2011-01-25 | 2016-02-17 | ザ プロクター アンド ギャンブルカンパニー | リポソーム及びそれを含むパーソナルケア組成物 |
| KR101224809B1 (ko) * | 2012-04-24 | 2013-01-21 | 주식회사 아이피어리스 | 레티노산 유도체, 이의 제조 방법 및 이를 포함하는 화장품 조성물 |
| EP2745904B1 (en) | 2012-12-21 | 2015-12-16 | Dionex Corporation | HILIC/Anion-Exchange/Cation-Exchange Multimodal Media |
| US9511144B2 (en) | 2013-03-14 | 2016-12-06 | The Proctor & Gamble Company | Cosmetic compositions and methods providing enhanced penetration of skin care actives |
| WO2015023926A1 (en) * | 2013-08-15 | 2015-02-19 | Mary Kay Inc. | Topical skin compositions for treating wrinkles |
| FR3054130B1 (fr) | 2016-07-22 | 2019-04-26 | Syntivia | Procede de traitement cosmetique de la peau |
| KR102093209B1 (ko) * | 2017-05-11 | 2020-03-25 | (주)케어젠 | 이소트레티노인과 펩타이드의 결합체 |
| US11148998B2 (en) | 2017-05-23 | 2021-10-19 | The Regents Of The University Of Michigan | Dimethyl-nonatetraenyl-trimethyl-cyclohexyl compounds and uses thereof |
| WO2018237218A1 (en) | 2017-06-23 | 2018-12-27 | The Procter & Gamble Company | COMPOSITION AND METHOD FOR ENHANCING SKIN APPEARANCE |
| KR20210011964A (ko) | 2018-07-03 | 2021-02-02 | 더 프록터 앤드 갬블 캄파니 | 피부 병태를 치료하는 방법 |
| KR102076178B1 (ko) * | 2018-07-18 | 2020-02-11 | 주식회사 코리아나화장품 | 초유 및 오르니틴을 유효성분으로 함유하는 피부 주름 개선용 화장료 조성물 |
| KR20210092483A (ko) | 2020-01-16 | 2021-07-26 | 맹창남 | 모발 및 두피상태 개선용 화장료 조성물 |
| CN115843238B (zh) | 2020-06-01 | 2025-06-10 | 宝洁公司 | 改善维生素b3化合物渗透到皮肤中的方法 |
| US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
| CN117384073A (zh) * | 2022-07-11 | 2024-01-12 | 南京毓浠医药技术有限公司 | 一种维a酸醇胺类复合物及其制备方法和应用 |
| CN118121574A (zh) * | 2022-12-02 | 2024-06-04 | 南京毓浠医药技术有限公司 | 一种含维a酸组合物及其制备方法和用途 |
| KR20250136628A (ko) | 2024-03-08 | 2025-09-16 | 주식회사 에이치엔컴퍼니 | 모발 개선용 화장료 조성물 |
| CN118126119B (zh) * | 2024-05-10 | 2024-08-06 | 荷本世新(北京)生物科技有限公司 | 维a酸多肽衍生物及其制备方法和用途 |
| CN121517355A (zh) * | 2026-01-15 | 2026-02-13 | 珀莱雅化妆品股份有限公司 | 一种吡哆胺衍生物、制备方法及其应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH529742A (de) * | 1970-02-02 | 1972-10-31 | Hoffmann La Roche | Verfahren zur Herstellung von Vitamin-A-Säureamiden |
| US3950418A (en) * | 1970-02-02 | 1976-04-13 | Hoffmann-La Roche Inc. | Vitamin A acid amides |
| DE2300107C2 (de) * | 1973-01-03 | 1982-03-11 | Basf Ag, 6700 Ludwigshafen | Vitamin A-Säureanilid-4-carbonsäureäthylester, Verfahren zu seiner Herstellung und diesen enthaltende Zubereitungen |
| US4108880A (en) * | 1975-11-03 | 1978-08-22 | Johnson & Johnson | Esters of retinoic acid |
| CH661516A5 (de) * | 1983-12-08 | 1987-07-31 | Hoffmann La Roche | Phenylnonatetraenoylzuckerderivate. |
| US5559149A (en) * | 1990-01-29 | 1996-09-24 | Johnson & Johnson Consumer Products, Inc. | Skin care compositions containing retinoids |
| DE4032187C2 (de) * | 1990-10-10 | 1995-03-30 | Gradinger F Hermes Pharma | N-Retinoyl-L-aminomercapto-Verbindungen und Zwischenprodukte, Verfahren zu ihrer Herstellung und ihre Verwendung |
| DE19523079A1 (de) * | 1995-06-26 | 1997-01-02 | Basf Ag | Ester und Amide der 9(Z)-Retinsäure |
| ATE239701T1 (de) * | 1998-03-30 | 2003-05-15 | Lg Chemical Ltd | Polyethoxylierte retinamid-derivate und verfahren zu ihrer herstellung |
| JP4646408B2 (ja) * | 1999-03-02 | 2011-03-09 | 協和発酵バイオ株式会社 | 化粧料 |
| JP2001039997A (ja) * | 1999-07-29 | 2001-02-13 | Lion Corp | 安定化されたレチノイン酸類の誘導体、ならびにそれらを含有する外用剤組成物 |
| JP4221547B2 (ja) * | 2001-01-26 | 2009-02-12 | ライオン株式会社 | レチノイン酸類またはその誘導体を含有する組成物 |
| KR100439627B1 (ko) * | 2001-06-18 | 2004-07-12 | 주식회사 엘지생활건강 | 피부주름 예방 및 치료용 조성물 |
| WO2004010966A1 (ja) * | 2002-07-25 | 2004-02-05 | Lion Corporation | 外用剤組成物 |
| CN1197847C (zh) * | 2002-09-02 | 2005-04-20 | 复旦大学 | 化合物n－全反式维甲酰胺衍生物及其制备方法和应用 |
| EP1686957B1 (en) * | 2003-11-17 | 2012-03-07 | Sederma | Compositions containing mixtures of tetrapeptides and tripeptides |
-
2005
- 2005-07-01 BR BRPI0513145-6A patent/BRPI0513145A/pt not_active IP Right Cessation
- 2005-07-01 US US11/631,322 patent/US20070270472A1/en not_active Abandoned
- 2005-07-01 WO PCT/EP2005/007134 patent/WO2006005455A2/en not_active Ceased
- 2005-07-01 JP JP2007519691A patent/JP2008515770A/ja active Pending
- 2005-07-01 CN CN200580022901XA patent/CN101048375B/zh not_active Expired - Fee Related
- 2005-07-01 EP EP05755911A patent/EP1765773A2/en not_active Withdrawn
- 2005-07-01 KR KR1020077000471A patent/KR20070038509A/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008515770A5 (https=) | ||
| EP0468339B1 (en) | Alpha-keto-amide derivatives having protease inhibiting activity | |
| JP7010823B2 (ja) | 皮膚、毛髪、爪および／または粘膜の処置および／またはケアにおいて有用な化合物 | |
| ES2547762T3 (es) | Péptidos para uso en el tratamiento cosmético o farmacéutico de la piel, membranas mucosas y/o cuero cabelludo | |
| US4692459A (en) | Anti-hypertensive agents | |
| CN115594735B (zh) | 具有抗衰老作用的肽及其组合物和用途 | |
| JPH0437070B2 (https=) | ||
| KR20200024235A (ko) | 피부, 모발, 손톱 및/또는 점막의 치료 및/또는 관리에 유용한 화합물 | |
| FR2788777A1 (fr) | Utilisation cosmetique ou dermopharmaceutique de peptides pour la regulation des dysfonctionnements immunologiques cutanes et dans l'inflammation cutanee induits par le vieillissement ou par les u.v. | |
| ES2756350T3 (es) | Composiciones tópicas que comprenden aminoácidos no proteinogénicos y métodos de tratamiento de la piel | |
| WO2002076935A1 (en) | Novel a-lipoic acid derivative and use thereof | |
| AU2003264412A1 (en) | Melanin extinguisher | |
| CN113271920A (zh) | 用于化妆品的肽和组合物 | |
| KR100721687B1 (ko) | 항-염증제 및 이를 함유하는 화장품 및 피부 외용제 | |
| WO2024170606A1 (en) | Cyclic peptides with anti-aging efficacy | |
| EP1865950B1 (en) | Compounds useful as modulators of the proteasome activity | |
| EP3429577B1 (en) | N-lipoic -amino acid or peptide, derivatives and their uses | |
| JP2008174453A (ja) | 頭皮脱毛治療剤 | |
| JP2007530488A (ja) | 化粧品用途のためのアリールアルキル酸のアミノ酸およびペプチド共役体 | |
| JP5552741B2 (ja) | 亜鉛を有効成分として含有する美白剤 | |
| RU2853306C2 (ru) | Синтетический пептид и его косметическая или фармацевтическая композиция и применение | |
| KR20210145158A (ko) | 화장품에 사용하기 위한 펩타이드 및 조성물 | |
| JPH11343235A (ja) | アミノ酸誘導体および炎症因子活性化抑制剤 | |
| US12435056B2 (en) | N-lipoic-amino acid or peptide, derivatives and their uses | |
| JP2006232685A (ja) | メイラード反応阻害剤 |